BACKGROUND: Estrogen receptor related beta (ERRb, ESRRB/NR3B2) is an orphan receptor that shares significant sequence homology with estrogen receptors ERa and ERb. ERR family members are reported to exhibit constitutive transcriptional activity; however, little is known about the biological function of ERRb. In an attempt to delineate its role, we examined expression of ERRb in normal human endometrium, a tissue that undergoes cyclic remodelling under the influence of estrogen and progesterone. METHODS: Well-characterized endometrial tissue (n 5 31), including full-thickness biopsies, was obtained from women with regular menstrual cycles. RT -PCR was used to measure mRNA encoding ERRb, the peroxisome proliferator activated receptor gamma coactivators (PGC)-1a and b and to determine whether ERRb splice variant mRNAs were expressed. ERRb was immunolocalized using both single and double antibody immunohistochemistry. RESULTS: Total ERRb mRNA appeared higher in proliferative phase samples but results did not reach significance. Transcripts corresponding to the long-and short-splice variants of ERRb as well as PGC1a and b were detected but ERRbD10 was absent. ERRb protein was localized to cell nuclei within multiple endometrial cell types including the glands, stroma, endothelium and immune cells, including uterine natural killer (uNK) cells and macrophages. Fluorescent immunohistochemistry revealed that some cells co-expressed ERRb and ERa or ERb, for example, endothelial and uNK cells were ERRb1/ERb1. CONCLUSIONS: ERRb mRNA and protein are expressed in healthy human endometrium. Further studies are warranted to characterize the functional impact of ERRb on endometrial biology.
Introduction
Nuclear receptors (NR) act as ligand-activated transcription factors and affect tissue homeostasis in response to a range of signals, including steroid hormones and various endogenous and exogenous molecules (Aranda and Pascual, 2001) ; some NR superfamily members are reported to act in the absence of a cognate ligand. These orphan receptors include the NR3B subfamily, named estrogen receptor related (ERR) owing to their sequence homology to the estrogen receptors (ERa/ESR1 and ERb/ESR2) (Giguere, 1999; Giguere, 2002) . Three ERR genes have been cloned (ERRa/ESRRA, b/ESRRB and g/ESRRG). ERRs are reported to constitutively modulate transcription via estrogen response elements (ERE) or steroidogenic factor-1 response elements (SFRE/ERRE) in the regulatory regions of target genes (Giguere, 2002) . Initial research was aimed at establishing whether ERRs can stimulate the expression of genes in estrogen responsive tissues. For instance, it was reported that the osteopontin and pS2 gene promoters could be activated either by ERRa or by ERRb in a ligand-independent manner via interactions with ERE sequences (Vanacker, et al., 1999; Lu, et al., 2001) . Conversely, reporter gene assays also suggested that ligand-activated ERa (but not ERb) can activate the osteopontin promoter via an ERRE sequence (Vanacker, et al., 1999) . These studies pointed towards an interplay between ERs and ERRs in modulating gene expression of the same target genes.
In common with ERa and ERb, ERRs can be activated through post-translational modifications including phosphorylation (Driggers and Segars, 2002) , which may be induced by growth factors such as epidermal growth factor (Barry and Giguere, 2005) . In addition, their function is also regulated by the NR coactivators peroxisome proliferator-activated receptor gamma coactivators 1a and 1b (PGC1a/ PPARGC1A and PGC1b/PPARGC1B). These proteins are widely expressed, and they are thought to play a key role in the regulation of energy metabolism (Kamei, et al., 2003; Puigserver and Spiegelman, 2003) . Cell-based studies have shown that PGC1a enhances ERRa expression and ERRa transcriptional activity via direct interaction between the coactivator and the NR (Schreiber et al., 2003) . Finally, these coregulators are themselves post-translationally regulated in response to stimuli such as dietary signals or infection (Puigserver and Spiegelman, 2003) , adding an additional layer of control to transcriptional regulation of ERR target genes and further flexibility to the phenotypic adaptation of cells to their environment.
The human endometrium undergoes cyclic remodelling under the influence of sequential exposure to the ovarian steroids estradiol and progesterone (Jabbour et al., 2006) . As each cycle progresses, component cells of the endometrium serially proliferate and differentiate in preparation for implantation of the conceptus; in the absence of pregnancy, the upper functional layer is shed (menses). A complex series of biological processes is involved in these pivotal reproductive events, including the regulation of cell division, the metabolism of several biochemical mediators and the inflammatory response. Although the precise molecular and cellular mechanisms by which steroid hormones promote uterine receptivity are still the subject of intensive investigation, it is generally accepted that estradiol and progesterone, acting via their cognate receptors, ensure a pattern of gene expression that facilitates implantation and the early stages of pregnancy. Dysfunctional regulation of these events may result in subfertility and various reproductive tract pathologies, including implantation failure and aberrations of menstrual bleeding (Jabbour et al., 2006; Talbi, et al., 2006; Aghajanova, et al., 2008) .
The processes that regulate endometrial function need to be controlled both temporally and spatially, thereby making the study of transcriptional regulators paramount in our understanding of endometrial biology. The pattern of expression of ER subtypes in the endometrium has been reported previously (Critchley et al., 2001 (Critchley et al., , 2002 . We have also documented the pattern of expression of NR in the uterine natural killer cells (uNK), which represent a major fraction of the endometrial immune cell population, especially in the luteal phase (Moffett and Loke, 2006) and demonstrated that these cells express ERb and glucocorticoid receptor (GR) but not ERa or the progesterone receptor (PR) (Henderson et al., 2003) . As an extension of these investigations and because ERRs and ERs appear to be functionally connected, we initiated a study to determine if ERRb was also expressed in the endometrium. While this work was being carried out, a paper was published describing three ERRb splice variants: a long form consisting of 11 exons, a short form lacking exons 10 and 11 and a form missing exon 10 (ERRbD10) (Zhou et al., 2006) . It was reported that none of these variants was expressed in three human samples described as 'uterus' (Zhou et al., 2006) . In the present paper, we report that both ERRb shortand long-form mRNAs are expressed in the normal human endometrium, that total transcript levels do not appear to vary significantly over the span of the endometrial cycle, although there appeared to a trend for them to be higher during the proliferative phase, and that the protein can be detected in the nuclei of multiple cells types, including immune and endothelial cells.
Materials and Methods

Sample collection
Endometrial biopsies were collected at different stages of the menstrual cycle with either an endometrial suction curette (Pipelle, Laboratoire CCD, Paris, France) or a full-thickness sample (surface epithelium to endometrial-myometrial junction) from women attending the gynaecological services at the Royal Infirmary, Edinburgh, UK. All women from whom endometrial tissue was collected provided written informed consent for biopsy collection, and there was institutional ethical approval. Subjects were of reproductive age (median 40 years; range 30 -48 years) and all described regular menstrual cycles (25-35 days length). Endometrial tissue was collected from women at the time of hysterectomy, laparoscopic sterilization or hysteroscopy. At the time of recruitment, no subject was known to have endometriosis or submucus fibroids. No subject had taken a sex steroid hormonal preparation during the 3 months prior to biopsy collection. Endometrial tissue was fixed in 4% neutral buffered formalin overnight at 48C before being routinely wax embedded for immunohistochemical assessment. In addition, endometrial tissue was either snap frozen in liquid nitrogen or placed in RNA Later (Ambion) overnight at 48C for subsequent RNA extraction. Histological dating of the samples was performed according to the criteria of Noyes (Noyes et al., 1950) . Serum samples collected at the time of endometrial biopsy were used for determination of circulating estradiol and progesterone concentrations by radioimmunoassay (Table I) . These were consistent with the patient's reported last menstrual period and a histological dating assessment that was undertaken by an expert histologist (Critchley et al., 2001 (Critchley et al., , 2002 . Numbers of samples used for RNA extraction were menstrual n ¼ 5, proliferative n ¼ 8, early secretory n ¼ 7, mid-secretory n ¼ 4 and late secretory n ¼ 7. For immunohistochemistry, 3-5 independent samples were examined at each stage.
Gene expression analysis
RNA was extracted using an RNeasy kit (QIAGEN); expression levels of mRNAs were determined by Taqman TM quantitative RT-PCR (qRT-PCR). Assay on demand TM primer/probe sets specific for ERRb (Hs01584021_m1: detects a region common to all splice variants) and ERa (Hs00174860_m1) were from Applied Biosystems; data were normalized by measuring 18S ribosomal RNA (assay 4308329) in the same reactions. Transcript abundance was expressed as a ratio against a standard comparator sample run with all plates that consisted of complementary DNA made from an ERa-positive endometrial adenocarcinoma Ishikawa cell line (Nishida et al., 1985) . The sequences of primers specific for the amplification of ERRb short-form (hERR2f1328 and hERR2r1690), long-form (hERRB2f1565 and hERRB2r1833) and ERRbD10 (hERRB2f1607 and hERRB2r2151) have been published (Zhou et al., 2006) . Messenger RNA was detected using a PCR-based method (Zhou et al., 2006) with minor modifications as follows: RNA extracted from samples was reverse transcribed using oligo-dT primers and analysed by touchdown PCR. The conditions were as follows: 5 min at 948C, then 10 cycles for 30 s at 948C, 30 s at 608C, with the temperature decreasing by 0.58C every cycle, 45 s at 728C, followed by 25 cycles for 30 s at 948C, 30 s at 558C, 45 s at 728C and a final extension step for 10 min at 728C.
For the detection of the NR coactivators, primers were designed against PGC1a using GenBank sequence NM_013261 (PGC1a forward: 5 0 -GCG CTG ACA GAT GGA GAC GT-3 0 and PGC1a reverse: 5 0 -TCT GTG GGT TTG GTG TGA GG-3 0 ) and PGC1b using sequence NM_133263 (PGC1b forward: 5 0 -TGG AGA GCC CCT GTG AGA GT-3 0 and PGC1b reverse: 5 0 -TCG CTC TGG GTG CTT CTT TG-3 0 ). A standard PCR protocol was applied for 30 cycles and using the annealing temperature of 598C. The reactions yielded products of size 347 and 350 bp for PGC1a and PGC1b, respectively. Following amplification, products were visualized on 1.5% (w/v) agarose gels, purified and sequenced. In parallel reactions where reverse transcriptase was omitted, no amplicons were detected. Control reactions containing primers directed against glyceraldehyde-3-phosphate dehydrogenase (GAPDH forward: 5 0 -CTG CAC CAC CAA CTG CTT AGC-3 0 ; GAPDH reverse: 5 0 -ATG CCA GTG AGC TTC CCG TTC-3 0 ) were carried out using an annealing temperature of 588C and 30 cycles of a standard PCR protocol yielding a 204 bp product. Reverse transcription and PCR were carried out using Omniscript and HotStart Taq polymerase (Qiagen) following the manufacturer's instruction.
Immunohistochemistry
Tissue samples were fixed in 4% neutral buffered formalin and embedded in paraffin wax. A list of all the antibodies and reagents used in this study can be found in Table II . To confirm the specificity of the anti-ERRb antibody, a blocking peptide (LS-P7128, LifeSpan Biosciences) was pre-incubated overnight with an aliquot of the antibody (10 mg peptide per microgram antibody) and immunohistochemistry performed as below.
Single antibody staining Slide-mounted 5 mm sections were deparaffinized, rehydrated and subjected to heat-induced antigen retrieval in a pressure cooker containing 0.01 M citrate buffer. The sections were then incubated with 3% hydrogen peroxide in methanol for 30 min to block endogenous peroxidase. All incubations are carried out at room temperature unless otherwise stated and were carried out in Tris-buffered saline (TBS; 50 mM Tris pH 7.4, 0.85% saline). Slides were blocked for 30 min in normal goat serum (NGS, Biosera) diluted 1:4 in TBS containing 5% bovine serum albumin, and an avidin-biotin block was performed as per manufacturer's instructions, using reagents from Vector (Peterborough, UK). Rabbit anti-ERRb was diluted 1:500 in NGS/ TBS/BSA and incubated on sections overnight at 48C; after washes in TBS, sections were incubated with GARB (goat anti-rabbit biotinylated) diluted 1:500 in NGS/TBS/BSA for 30 min. After further washes in TBS, sections were incubated in Streptavidin-horse-radish peroxidase for 30 min, washed in TBS (twice for 5 min each time) and bound antibodies were visualized by incubation with 3,3'-diaminobenzidine tetra-hydrochloride (liquid DABþ, product no. K346811 from DAKO).
Double antibody fluorescent immunohistochemistry
Slides were subjected to antigen retrieval as described above. The procedures for the double fluorescent immunohistochemistry are presented in Table III ; all detections were performed sequentially. After blocking, washes between antibody incubations were performed twice for 5 min each using phosphate-buffered saline instead of TBS.
Slides were examined using a Zeiss LSM Meta-confocal microscope fitted with a motorized stage. For the study of the full-thickness tissue (encompassing the functionalis and basalis layers of the endometrium and the myometrium), a tiled montage 1 frame wide by 8-10 frames in depth was acquired. Once settings were optimized for the brightest staining section, all further images were taken at the same settings to allow comparison.
Statistical analysis
Statistical analysis was carried out with Prism (GraphPad). Data normality was assessed with a Kolmogorov-Smirnov test and the 
Results
Expression of ERRb mRNA(s) in normal human endometrium Expression of ERRb mRNA was detected in the human endometrium throughout the menstrual cycle using qRT -PCR. There were no significant differences between samples obtained at different stages of the cycle (P ¼ 0.679), although there was a suggestion that the levels were higher in the proliferative and early secretory phases (Fig. 1A) . In line with expectations (Henderson et al., 2003) when ERa mRNA was measured in the same set of samples, highest levels of expression were detected in proliferative and early secretory phases (P ¼ 0.0052) (Fig. 1B) . The existence of ERRb splice variant mRNAs in normal cycling endometrium was investigated with a PCR-based assay. In the proliferative phase, mRNAs corresponding to both the short and long forms of ERRb were detected in three of four samples, in the remaining sample only the ERRb short form was detected (Fig. 2, lane 1) .
The same pattern was seen in RNA from tissues sampled at the mid-secretory phase, and mRNA corresponding to the ERRbD10 form was never detected; although this method is only semi-quantitative, transcript abundance appeared higher in samples from the proliferative phase. All three transcripts were expressed in RNA prepared from human kidney, which was used as a positive control (Fig. 2K ). Expression of mRNA encoding PGC1a was detected in all proliferative phase samples and three of four samples from the midsecretory phase. PGC1b mRNA was present in all four proliferative phase samples and in three out of four samples from the mid-secretory phase (Fig. 2) . -4) and mid-secretory (lane 5-8) phase endometrium. The abbreviations on the right-hand side indentify DNA amplied with primers specific for the following: ERRb short form (SF), ERRbD10 (D10), ERRb long form (LF), PGC1a, PGC1b and GAPDH. The experiment was repeated three times and similar results were obtained on each occasion.
Expression of ERRb protein
Western blotting of nuclear proteins from Ishikawa cells infected with a virus expressing the short form of ERRb resulted in binding of antibody to a protein of the expected size (45 kDa), which was not detected when the membrane was probed with pre-absorbed antibody (not shown). ERRb protein was immunolocalized to multiple cell types within the endometrium using an antibody directed against a sequence that is present in both the long and short forms of the protein (Fig. 3A -F) . Specificity was confirmed by incubation of antibody with the immunising peptide ( Fig. 3A 0 , inset) and positive nuclear staining was demonstrated in breast cancer tissue ( Fig. 3G ) and the cytotrophoblast cells within term placenta (Fig. 3H ). Immunopositive staining for ERRb was detected in the nuclei of cells within the glandular epithelium (g in Fig. 3B -D) , the stroma as well as in the endothelial cells of blood vessels (Fig. 3D, arrows) . There was no obvious stage-dependent change in the intensity of immunoexpression using this method of immunohistochemistry.
ERRb was co-expressed with ERa or ERb in some cell types within the endometrium Fluorescent immunohistochemistry using full-thickness endometrial biopsies revealed that expression of ERRb was different to that of either ERa (Fig. 4) or ERb ( Supplementary  Fig. S1 ). For example, during the proliferative and early secretory phases, the intense immunoexpression of ERa in the glandular epithelium of the functional layer masked the immunostaining of ERRb (Figs 4 and 5A) , whereas ERRb appeared to be expressed in a higher proportion of the stromal cells and was readily detected in ERa-negative endothelial cells (Fig. 5A inset, arrows) . Expression of ERRb was maintained in the epithelial cells within the functional layer in the late secretory phase when ERa was no longer detectable ( Fig. 5C ); expression of ERa in the basal compartment was maintained throughout the cycle (Fig. 4) . In full-thickness samples obtained from the mid-proliferative and early secretory phases, groups of cells that were ERRb positive/ERa negative were present within the basal compartment (Fig. 4, arrow heads) . At all stages of the cycle ERRb and ERb were co-expressed in multiple cell types in both the stromal and epithelial cell compartments of the functional layer ( Fig. 5B and D yellow nuclei). Endothelial cells were immunopositive for both ERRb and ERb although ERb immunopositive staining was intense in the myometrial layer, whereas expression of ERRb was low/negative ( Supplementary Fig. 1, unpublished data) .
ERRb was expressed in immune cell populations within the normal endometrium Leukocyte populations within the endometrial stromal cell compartment vary during the menstrual cycle and include macrophages, neutrophils and uNK cells. Immunopositive staining for ERRb was detected in cell nuclei of immune cell populations identified by double fluorescent immunohistochemistry as being leukocytes (CD45 positive, Fig. 6A and  B) , uNK cells (CD56 positive, Fig. 6C and D) and macrophages (CD68 positive, Fig. 6E and F) . Furthermore, in the endometrial samples where spatial orientation of the tissue was maintained, we observed large groups of ERRb positive cells that did not appear to be ERa or ERb positive (Fig. 4) . We speculate that these cells are immune cell aggregates that are known to occur in the basal layer of the human endometrium (Marshall and Jones, 1988) .
Discussion
In this study, we have demonstrated for the first time that mRNAs encoding ERRb long and short forms, but not ERRbD10, are expressed in human endometrium at all stages of the cycle. The function of NR is modulated by receptor coactivators, it was therefore important that we were also able to demonstrate expression of mRNAs for PGC1a and b. ERRb protein was detected in immune cells including macrophages and uNK cells as well as in endothelial cells where it was co-expressed with ERb. The total amount of ERRb mRNA was low compared with that for ERa and, together with a certain amount of interindividual variability, this may explain why a previous study (Zhou et al., 2006) failed to detect expression in uterine RNA samples of commercial origin, using identical PCR cycling conditions. Although the results did not reach significance using both semi-quantitative and qRT -PCR, there was a trend for ERRb mRNAs to be higher in samples from the proliferative phase. In preliminary experiments, we have failed to detect any consistent change in expression following treatment of epithelial and stromal endometrial cell lines with either estradiol or progestagen; however, bioinformatic analysis has revealed the presence of putative PR binding sites in the 5 0 region of the ERRb gene (unpublished observation). In ERRa knockout mice, kidney ERRb mRNA levels were reduced compared with those in wild-type littermates, suggesting that the amount of ERRa might influence expression of ERRb in this tissue (Luo et al., 2003) . Data showing that expression of ERRa is up-regulated by estradiol treatment in the mouse uterus (Shigeta et al., 1997) , the HEC-1 human endometrial adenocarcinoma cell line and MCF-7 breast cancer cells (Liu et al., 2003) have been published. These authors reported that the estrogenic response was mediated by a 34 bp DNA element containing multiple steroid hormone response element half-sites that are conserved between the human and mouse ERRa gene promoters (Liu et al., 2003) . However, when we carried out sequence alignment analysis of 10 kb in the 5 0 region of ERRa and b, we failed to detect this response element in the ERRb promoter and further studies are needed to establish the role played, if any, by steroid hormones in regulating ERRb mRNA expression in vivo.
In contrast to a previous paper that reported that ERRb was immunolocalized within the cytoplasmic compartment [Gao et al., 2006 , we consistently detected the protein in the nuclear compartment, a finding that is in agreement with nuclear localization of fluorescent protein tagged constructs (Zhou et al., 2006) and our unpublished data]. The commercial antibody we used was directed against a peptide present in both long and short forms of ERRb, and although the results of our RT -PCR studies would suggest that both forms were expressed in the same samples, this would need to be elucidated using a new antibody specific to the C-terminal domain of the ERRb long-form protein.
NR coactivators have an important impact on NR signalling, through remodelling of the local chromatin environment and recruitment of the transcription machinery (McKenna et al., 1999) . Other reports have described the expression of NR regulatory proteins within the endometrium, including SRC1 (steroid receptor coactivator 1), and the corepressors NCoR (nuclear receptor corepressor) and SMRT (silencing mediator of retinoid and thyroid) (Shiozawa et al., 2003) . Dysregulation of NR coactivators has been reported to occur in the endometrium of women with polycystic ovarian syndrome (Gregory , 2002) . Although the PGC-1 family of NR coactivators is reported to interact with several different NR, they appear to be critical regulators of ERR protein activity and are considered to act as 'protein ligands' for this class of orphan receptor (Huss et al., 2002; Kamei et al., 2003) . PGC1a binds to ERRa via a specific leucine-rich domain that is distinct from the region involved in binding to other NR, including ERa (Huss et al., 2002) . Results from in vitro transactivation assays suggest that ERRb can also be regulated by PGC1b (Kamei et al., 2003) . In silico comparisons between ERRa and ERRb protein sequences (our unpublished observation) reveal that the region associated with binding to PGC1a is conserved between the proteins.
The endometrium contains a diverse population of immune cells that play a vital role in maintaining a balance between protecting the tissue from pathogenic attacks and tolerating the allogeneic sperm and trophoblast cells (Lea and Sandra, 2007) . In the present study, we have demonstrated that ERRb can be immunolocalized to uNK cells, macrophages and leukocytes within the functional layer of the endometrium and to aggregates of cells within the basal compartment that we also believe to be immune cells. uNK cells have a unique phenotype (CD56 bright , CD16 2 and CD3 2 ), distinguishing them from peripheral blood NK cells (CD56 dim , CD16 bright and CD3 2 ). They are the major immune cell population in the late secretory phase and early pregnancy, and they play a key role in implantation and early placentation (Moffett and Loke, 2006; Lea and Sandra, 2007) . The cyclical change in uNK cell number in the endometrium suggests that this cell type may be regulated by changes in the amounts of sex steroid hormones. We have previously demonstrated that uNK express ERb and GR but not ERa (Henderson et al., 2003) and recently discovered that they also express ERRa (unpublished observations). The function of uterine macrophages is less clearly defined, but we speculate that they may be involved in clearing extracellular components from degraded cells (Repnik et al., 2008) . Studies in mice lacking ERRa demonstrate that it is required for induction of mitochondrial reactive oxygen species production in macrophages, a response that was also dependent upon PGC-1b (Sonoda et al., 2007) . We believe that our data are the first to demonstrate expression of ERRb in immune cells within endometrium and further studies are therefore required to determine the significance of this result.
Since ERRb and the ERR coactivators PGC1a and b are all expressed in the human endometrium, it is appropriate to consider how the protein might influence endometrial function. On the basis of the available literature on the function(s) of ERRs, we speculate that ERRb might have an impact on ER signalling, influence expression of previously identified ERR target genes and/or influence cell differentiation. The evidence for each of these functions is considered below.
In the current study, we found that immunoexpression of ERRb in normal endometrium occurred in multiple cell populations within the normal endometrium. Although some cells appeared to express ERRb alone (e.g. immune aggregates), in other cell types, the receptor was co-expressed with ERa (e.g. epithelial cells in the proliferative phase) or ERb (e.g. endothelial cells, uNK cells). We have also detected expression of ERRb in stage 1 endometrial cancers (unpublished observations), and it is notable that expression of ERRa also occurs in endometrial cancers where it has been suggested that it may be linked to dysregulation of estrogen signalling (Watanabe et al., 2006) . Experiments support the idea that ERRa and ERRb proteins both have the ability to bind to identical ERE and ERRE sequences (Vanacker et al., 1999) . Genes expressed in the human endometrium that contain promoters reported to be regulated by ERRa include lactotransferin (Yang et al., 1996) , thyroid hormone receptor a (Vanacker et al., 1998a,b) , osteopontin (Vanacker et al., 1998a,b) , aromatase (CYP19) (Yang et al., 1998) and monoamine oxidase (Zhan et al., 2004) ; therefore, our data showing expression of ERRb raises the possibility that this protein may also influence expression of the same set of genes.
There is an emerging consensus that ERRs play a key role in regulating genes involved in energy homeostasis, including fatty acid metabolism . For example, transgenic mice lacking ERRa have a reduced fat mass and are resistant to diet-induced obesity (Luo et al., 2003) . To date, there is no data to support a similar role for ERRb and this therefore requires further study. Finally, a number of recent papers report a role for ERRb with the regulation of stem cell differentiation (Ivanova et al., 2006; Loh et al., 2006) . In murine embryonic stem cells, ERRb is not only a direct target of the stem cell regulator Oct4, but also acts as a transcription factor regulating Oct4 (Zhou et al., 2007) . Studies in ERRb knock-out animals have revealed problems with differentiation of trophoblast, and viable knock-out animals can only be generated by aggregating mutant embryos with wild-type cells which can then develop a functional placenta (Luo et al., 1997) . Additionally, ERRb is expressed in primordial germ cells during embryonic life and gene deficiency leads to a reduction in the number of differentiated germ cells (Mitsunaga et al., 2004) ; therefore, we propose that ERRb may also have an impact on endometrial cell differentiation.
In summary, we have demonstrated for the first time that ERRb short and long splice variant mRNAs are both expressed in the human endometrium. ERRb protein is expressed within the cell nuclei of epithelial, stromal, immune and endothelial cells. Expression of the protein partially overlaps with that of ERa and ERb. We speculate that ERRb may play a role in endometrial cell fate determination and in regulating factors important for endometrial function and receptivity, including osteopontin. Clearly, further studies are required to uncover the full impact of expression of ERRb in endometrial biology and investigate whether there are differences in the functional effects of the splice variant isoforms. Figure 6 : ERRb protein is expressed in immune cell populations within the human endometrium. Co-localization of ERRb (red nuclei) with surface markers for selected immune cell populations (all green), counterstain for cell nuclei was DAPI (blue). (A and B) CD45 leukocyte common antigen (green); (C and D) CD56 (green), uNK cells; (E and F) CD68 (green), uterine macrophages. Magnification panels A, C and E all Â20, scale bar 100 microns; panels B, D and F are cropped highpower views from the same samples.
